Skip to search boxSkip to navigationSkip to main content

MYC as a regulator of ribosome biogenesis and protein synthesis

  • Jan Van Riggelen
    ,
  • Alper Yetil
    ,
  • Dean W. Felsher
  • Stanford University
Scholary Output:
Contribution to journal
Comment/debate
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

MYC regulates the transcription of thousands of genes required to coordinate a range of cellular processes, including those essential for proliferation, growth, differentiation, apoptosis and self-renewal. Recently, MYC has also been shown to serve as a direct regulator of ribosome biogenesis. MYC coordinates protein synthesis through the transcriptional control of RNA and protein components of ribosomes, and of gene products required for the processing of ribosomal RNA, the nuclear export of ribosomal subunits and the initiation of mRNA translation. We discuss how the modulation of ribosome biogenesis by MYC may be essential to its physiological functions as well as its pathological role in tumorigenesis.

Publication Information

Output type

Scholary Output:
Contribution to journal
Comment/debate
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 301-309 (9 pages)

Journal (Volume, Issue Number)

Nature Reviews Cancer (Volume 10, Issue 4)

Publication milestones

  • Published - 04/2010

Publication status

Published - 04/2010

ISSN

1474-175X

Publication IDs

  • Scopus: 77949920493
  • PubMed: 20332779

Publication metrics

Metrics

SciVal
FWCI
24.09
SciVal
Author count
3
SciVal
citations
484
SciVal
Paper percentile
99
SciVal
Top percentile
1
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Social media
1
Mentions
1
Captures
765
Citation count
826

Funding Details

The authors are supported by research funds from a Canada research chair in proteomics, the Canadian Institutes of Health Research (CIHR grants MOP-74648 and IG1-14052), the Cancer Research Society, the Alberta Cancer Board and the National Institutes of Health (NIH grant P50 CA136393-01). We thank the Felsher laboratory for critical reading of the manuscript. Our work is supported by the National Institutes of Health, the Leukemia and Lymphoma Society and the Burroughs Wellcome Fund.